Background Pancreatic ductal adenocarcinoma (PDAC) remains one of the most lethal cancers due to its aggressive biology and ...
Rapid scientific progress has given us the tools to stop time more convincingly than ever – but lurking behind these claims ...
Spinal cord injury (SCI) leads to devastating and often irreversible loss of sensory and motor function due to the limited regenerative capacity of the ...
A cutting-edge mini-review published in the inaugural issue of Targetome elaborates on the value of proteome-wide ...
Viral immunopathology and fibrogenesis research has revealed that viral infections can instigate long-lasting structural and functional alterations across ...
LET’S GET TECHNICAL. Scientists from the biotech company Life Biosciences are investigating the safety and potential side ...
Morning Overview on MSN
The first cellular age-reversal therapy has been cleared for human trials
Life Biosciences has received FDA clearance to begin a first-in-human Phase 1 clinical trial of ER-100, a gene therapy ...
A groundbreaking human trial of ER-100, a cellular reprogramming therapy, has begun, testing whether damaged eye cells can be rejuvenated and potentially opening a new chapter in the science of aging.
Proprietary Synthetic Polynucleotide Platform Accelerates Non-Viral, Footprint-Free Induced Pluripotent Stem Cell Generation Amid Surging Commercialization of iPSC Therapies in JapanSEATTLE, June 16, ...
Promising mouse studies and billions of dollars in funding are stoking excitement. But we’ve been here before.
Cellular reprogramming is the hottest topic in longevity science, with tech titans like Sam Altman investing in it. It's now being tested in humans.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results